Genomic Testing in Neurological Tumours
There are 31 Clinical Indications included in the Cancer National Genomics Test Directory for neurological tumours . For each of the clinical indications listed below testing is provided by all 7 Genomic Laboratory Hubs across England. The test directory includes both targeted genetic testing and panel testing using next generation sequencing (NGS) technology. The West Midlands Regional Genetics Laboratory provides a centralised cancer panel testing service (both DNA and RNA panels) for the Central and South GLH Consortium.
Genetic testing services for neurological tumours are currently in development.
DNA and RNA panels however are available. Please contact Dr Yvonne Wallis (firstname.lastname@example.org) to discuss your requirements.
Please use the WMRGL Cancer Genomic Test Request Form [pdf] 147KB.